Crandell Keith
- SEC CIK
- 0001219039
In the past year, 2 open-market purchase filings worth $32.3M and no sales.
Current role at each company
- BOLD Boundless Bio, Inc.10% Owneras of Jul 6, 2026
- KARD Kardigan, Inc.Director, 10% Owneras of Jun 24, 2026
- MASS 908 Devices Inc.Directoras of Jun 12, 2026
- SPTX Seaport Therapeutics, Inc.10% Owneras of May 4, 2026
- LYEL Lyell Immunopharma, Inc.10% Owneras of Mar 9, 2026
Show 12 more companies
- TWST Twist Bioscience CorpDirectoras of Feb 9, 2026
- MTSR Metsera, Inc.Director, 10% Owneras of Nov 14, 2025
- NMRA Neumora Therapeutics, Inc.10% Owneras of Oct 29, 2025
- PRME Prime Medicine, Inc.10% Owneras of Aug 1, 2025
- RAPP Rapport Therapeutics, Inc.10% Owneras of Jun 10, 2024
- SANA Sana Biotechnology, Inc.10% Owneras of Feb 12, 2024
- DALS DA32 Life Science Tech Acquisition Corp.Director, 10% Owneras of Aug 10, 2023
- QTRX Quanterix CorpDirectoras of Apr 4, 2023
- CDAK Codiak BioSciences, Inc.10% Owneras of Sep 15, 2022
- VIR Vir Biotechnology, Inc.10% Owneras of Sep 7, 2022
- ERAS Erasca, Inc.10% Owneras of Jul 20, 2021
- BEAM Beam Therapeutics Inc.10% Owneras of Jul 2, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $32.3M
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$32.3M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Crandell Keith as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BOLD Boundless Bio, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 (view filing)5:44 PM ET | Jul 1 | 5 days | Crandell Keith and 4 others10% Owner | SSale | −16.0K | $2.49 | −$39.8K | −100.0%0 after | Duplicate filing |
| Apr 4, 2024 (view filing)4:30 PM ET | Apr 2 | 2 days | Crandell Keith and 3 others10% Owner | PPurchase | +200.0K | $16.00 | +$3.20M | +20.4%1.18M after | 2 lotsDuplicate filing |
KARD Kardigan, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 (view filing)4:18 PM ET | Jun 22 | 2 days | Crandell Keith and 6 othersDirector, 10% Owner | PPurchase | +1.25M | $16.00 | +$20.0M | +9.1%15.0M after | Duplicate filing |
SPTX Seaport Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 (view filing)6:02 PM ET | May 4 | Same day | Crandell Keith and 6 others10% Owner | PPurchase | +1.10M | $18.00 | +$19.8M | +21.2%6.29M after |
LYEL Lyell Immunopharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 (view filing)4:34 PM ET | Mar 6 | 3 days | Berns Paul L and 8 others10% Owner | PPurchase | +488.1K | $25.61 | +$12.5M | +52.0%1.43M after |
NMRA Neumora Therapeutics, Inc.
10% Owner8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 (view filing)7:21 PM ET | Oct 27 | 2 days | Crandell Keith and 6 others10% Owner | PPurchase | +1.92M | $2.61 | +$5.00M | +46.4%6.05M after | Duplicate filing |
| Nov 15, 2023 (view filing)6:54 PM ET | Nov 13-14 | 2 days | Crandell Keith and 5 others10% Owner | PPurchase | +35.0K | $11.77 | +$412.1K | +0.9%4.13M after | 2 lotsDuplicate filing |
| Nov 13, 2023 (view filing)7:00 PM ET | Nov 8-10 | 5 days | Crandell Keith and 5 others10% Owner | PPurchase | +140.6K | $10.98 | +$1.54M | +3.6%4.10M after | 5 lotsDuplicate filing |
| Nov 7, 2023 (view filing)6:59 PM ET | Nov 3-7 | 4 days | Crandell Keith and 5 others10% Owner | PPurchase | +95.7K | $11.49 | +$1.10M | +2.5%3.96M after | 3 lotsDuplicate filing |
| Sep 29, 2023 (view filing)6:53 PM ET | Sep 28-29 | 1 day | Crandell Keith and 5 others10% Owner | PPurchase | +76.5K | $13.68 | +$1.05M | +2.0%3.86M after | 3 lotsDuplicate filing |
| Sep 27, 2023 (view filing)8:18 PM ET | Sep 26-27 | 1 day | Crandell Keith and 5 others10% Owner | PPurchase | +58.5K | $11.97 | +$700.5K | +1.6%3.78M after | 2 lotsDuplicate filing |
| Sep 25, 2023 (view filing)9:38 PM ET | Sep 22-25 | 3 days | Crandell Keith and 5 others10% Owner | PPurchase | +100.7K | $11.19 | +$1.13M | +2.8%3.72M after | 3 lotsDuplicate filing |
| Sep 20, 2023 (view filing)6:16 AM ET | Sep 19 | 1 day | Crandell Keith and 7 others10% Owner | PPurchase | +1.50M | $17.00 | +$25.5M | +70.6%3.62M after | Duplicate filing |
PRME Prime Medicine, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 (view filing)7:18 PM ET | Aug 1 | Same day | Crandell Keith and 7 others10% Owner | PPurchase | +3.03M | $3.30 | +$10.0M | +94.7%6.23M after | Duplicate filing |
| Feb 20, 2024 (view filing)5:37 PM ET | Feb 15 | 5 days | Crandell Keith and 7 others10% Owner | PPurchase | +3.20M | $6.25 | +$20.0M | New position3.20M after | Duplicate filing |
| Oct 26, 2022 (view filing)8:01 PM ET | Oct 24 | 2 days | Crandell Keith and 7 others10% Owner | PPurchase | +800.0K | $17.00 | +$13.6M | +15.0%6.13M after | 2 lotsDuplicate filing |
MTSR Metsera, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 (view filing)7:01 PM ET | Feb 3 | Same day | Crandell Keith and 8 others10% Owner | PPurchase | +2.22M | $18.00 | +$40.0M | +36.5%8.31M after | 2 lotsDuplicate filing |
SANA Sana Biotechnology, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 (view filing)5:43 PM ET | Feb 8 | 4 days | Crandell Keith and 3 others10% Owner | PPurchase | +1.82M | $5.50 | +$10.0M | +17.1%12.4M after | 3 lotsDuplicate filing |
CDAK Codiak BioSciences, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 (view filing)6:53 PM ET | Sep 13 | 2 days | Crandell Keith and 6 others10% Owner | PPurchaseCommon Sotck | +5.00M | $1.50 | +$7.50M | +129.7%8.85M after | |
| Sep 15, 2022 (view filing)6:53 PM ET | Sep 13 | 2 days | Crandell Keith and 6 others10% Owner | PPurchase | +5.00M | – | – | –5.00M after | DerivativeDuplicate filing |
TWST Twist Bioscience Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 (view filing) | Aug 12 | 1 day | Crandell KeithDirector | SSale | −1.41K | $106.93 | −$151.0K | −74.4%486 after | |
| Aug 13, 2021 (view filing) | Aug 12 | 1 day | Crandell KeithDirector | SSale | −43.6K | $107.01 | −$4.66M | −36.4%76.0K after | 2 lots |
DALS DA32 Life Science Tech Acquisition Corp.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 (view filing) | Jul 30 | 4 days | Crandell KeithDirector, 10% Owner | PPurchaseClass A Common Stock | +1.60M | $10.00 | +$16.0M | New position1.60M after |